Trump Administration Prepares 100 Percent Drug Tariffs
The White House plans 100 percent tariffs on drugmakers lacking U.S. price deals. Major firms have secured exemptions or pledged local expansions to avoid penalties.
Xurve View
Insights:
Xurve View
The administration in the United States is reportedly preparing to impose significant tariffs on pharmaceutical companies that fail to secure pricing agreements with the government. According to reports from Bloomberg News, these measures could be announced as early as Thursday, targeting drugmakers that have not guaranteed lower costs for American consumers.
